295 related articles for article (PubMed ID: 23760250)
21. Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.
Du Pont V; Wirblich C; Yoon JJ; Cox RM; Schnell MJ; Plemper RK
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321812
[TBL] [Abstract][Full Text] [Related]
22. A Novel Rabies Vaccine Expressing CXCL13 Enhances Humoral Immunity by Recruiting both T Follicular Helper and Germinal Center B Cells.
Wang Z; Li M; Zhou M; Zhang Y; Yang J; Cao Y; Wang K; Cui M; Chen H; Fu ZF; Zhao L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852854
[TBL] [Abstract][Full Text] [Related]
23. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
[TBL] [Abstract][Full Text] [Related]
24. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice.
Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X
Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572
[TBL] [Abstract][Full Text] [Related]
25. AAV-expressed G protein induces robust humoral and cellular immune response and provides durable protection from rabies virus challenges in mice.
Liu C; Li J; Yao Q; Gao Z; Cheng Y; Zhou M; Tang Y; Sun L; Dai J; Cao G; Zhang XL; Zhang R
Vet Microbiol; 2020 Mar; 242():108578. PubMed ID: 32122589
[TBL] [Abstract][Full Text] [Related]
26. A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.
Chen Z; Zhou M; Gao X; Zhang G; Ren G; Gnanadurai CW; Fu ZF; He B
J Virol; 2013 Mar; 87(6):2986-93. PubMed ID: 23269806
[TBL] [Abstract][Full Text] [Related]
27. Rabies DNA vaccination by the intranasal route in dogs.
Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2.
Nokireki T; Jakava-Viljanen M; Virtala AM; Sihvonen L
Acta Vet Scand; 2017 Oct; 59(1):64. PubMed ID: 28969696
[TBL] [Abstract][Full Text] [Related]
29. Rabies virus glycoprotein serology ELISA for measurement of neutralizing antibodies in sera of vaccinated human subjects.
Zhao R; Yu P; Shan Y; Thirumeni N; Li M; Lv Y; Li J; Ren W; Huang L; Wei J; Sun Y; Zhu W; Sun L
Vaccine; 2019 Sep; 37(41):6060-6067. PubMed ID: 31471146
[TBL] [Abstract][Full Text] [Related]
30. Essential Role of T cells in the postexposure prophylaxis of rabies in mice.
Mifune K; Takeuchi E; Napiorkowski PA; Yamada A; Sakamoto K
Microbiol Immunol; 1981; 25(9):895-904. PubMed ID: 6171709
[TBL] [Abstract][Full Text] [Related]
31. Exhaustive Exercise Does Not Affect Humoral Immunity and Protection after Rabies Vaccination in a Mouse Model.
Xia L; Li M; Zhang Y; Ruan J; Pei J; Shi J; Fu ZF; Zhao L; Zhou M; Tian D
Virol Sin; 2018 Jun; 33(3):241-248. PubMed ID: 29594957
[TBL] [Abstract][Full Text] [Related]
32. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
[TBL] [Abstract][Full Text] [Related]
33. Intracerebral transfection of anti-rabies virus antibodies is an effective therapy for rabies.
Agostinho WC; Brandão PE
J Neurovirol; 2020 Oct; 26(5):764-768. PubMed ID: 32725420
[TBL] [Abstract][Full Text] [Related]
34. Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.
Um J; Chun BC; Lee YS; Hwang KJ; Yang DK; Park JS; Kim SY
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006084. PubMed ID: 29267277
[TBL] [Abstract][Full Text] [Related]
35. Addition of C3d-P28 adjuvant to a rabies DNA vaccine encoding the G5 linear epitope enhances the humoral immune response and confers protection.
Galvez-Romero G; Salas-Rojas M; Pompa-Mera EN; Chávez-Rueda K; Aguilar-Setién Á
Vaccine; 2018 Jan; 36(2):292-298. PubMed ID: 29191739
[TBL] [Abstract][Full Text] [Related]
36. T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System Tissue.
Lebrun A; Portocarrero C; Kean RB; Barkhouse DA; Faber M; Hooper DC
J Immunol; 2015 Nov; 195(9):4358-68. PubMed ID: 26408670
[TBL] [Abstract][Full Text] [Related]
37. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.
Koraka P; Bosch BJ; Cox M; Chubet R; Amerongen Gv; Lövgren-Bengtsson K; Martina BE; Roose J; Rottier PJ; Osterhaus AD
Vaccine; 2014 Aug; 32(36):4644-50. PubMed ID: 24962755
[TBL] [Abstract][Full Text] [Related]
38. Intracerebral vaccination suppresses the spread of rabies virus in the mouse brain.
Sunden Y; Yano S; Ishida S; Ochiai K; Umemura T
Microbes Infect; 2010 Dec; 12(14-15):1163-9. PubMed ID: 20713172
[TBL] [Abstract][Full Text] [Related]
39. Efficiency of live attenuated and inactivated rabies viruses in prophylactic and post exposure vaccination against the street virus strain.
Huang F; Ahmad W; Duan M; Liu Z; Guan Z; Zhang M; Qiao B; Li Y; Song Y; Song Y; Chen Y; Amjad Ali M
Acta Virol; 2015 Jun; 59(2):117-24. PubMed ID: 26104328
[TBL] [Abstract][Full Text] [Related]
40. A mouse model of the pathogenesis and postexposure prophylaxis of rabies.
Mifune K; Shichijo A; Makino Y; Takeuchi E; Yamada A; Sakamoto K
Microbiol Immunol; 1980; 24(9):835-45. PubMed ID: 6163950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
